Company · London
Alchemab Therapeutics LTD
Research and experimental development on biotechnology
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Alchemab Therapeutics LTD. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 8
- Young T. Kwon 2022-2024 View profile
- Professor Houman Ashrafian 2021-2023 View profile
- John Hamer 2021-2026 View profile
- Andrew David Levin 2021-2026 View profile
- Dr Douglas Treco 2021-2022 View profile
- Alexander Robert Leech 2019-2021 View profile
- James Allister John Costine 2019-2021 View profile
- Jonathon Alan Dines 2019-2020 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- What it does
- Research and experimental development on biotechnology
- Incorporated
- 14/08/2019
- Registered office
- London
Ownership
Owned by (2) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- SV7 (IMF) GP LLP ceased 2021-04-13
25-50% shares (firm), 25-50% voting (firm) · notified 2019-08-14 - Dementia Discovery GP LP ceased 2020-04-02
25-50% shares, 25-50% voting · notified 2019-08-14
Group
- Alchemab Therapeutics LTD
is controlled by SV7 (IMF) GP LLP
Evidence
ceased 25-50% shares (firm), 25-50% voting (firm) · notified 2019-08-14, ceased 2021-04-13 · source: Companies House PSC register - SV7 (IMF) GP LLP
is controlled by SV Health Investors UK Limited
Evidence
active 25-50% voting (LLP), 25-50% surplus assets (LLP), right to appoint and remove members (LLP) · notified 2019-01-17 · source: Companies House PSC register - SV Health Investors UK Limited
is controlled by Catherine Elizabeth Bingham
Evidence
active 50-75% shares, 50-75% shares (firm), 50-75% voting · notified 2016-04-06 · source: Companies House PSC register
Ultimately controlled by Catherine Elizabeth Bingham.
28 other companies in this group
- DDF 2 FP LP
- Harness Therapeutics Limited
- DDF 2 FP GP LLP
- DDF 2 GP LLP
- DDF Chemco Limited
- Dementia Discovery General Partner LLP
- SV BCO I FP GP LLP
- SV8 Biotech FP LP
- Loqus23 Therapeutics Limited
- Cybele Therapeutics LTD
- DDF Parallel LLP
- SV8 BIO FP GP LLP
- SV Health Investors UK Limited
- SV8 BIO GP LLP
- SV Health Managers LLP
- SV Health Investors LLP
- SV DDF Number 1 Limited
- SV BCO I GP LLP
- SV7 (IMF) FP LP
- Mestag Therapeutics LTD
- 10279592
- SV DDF Number 2 Limited
- Cellinta LTD
- Dementia Discovery GP LP
- SV7 (IMF) FP GP LLP
- Endlyz UK LTD
- SV BCO I FP LP
- SV7 (IMF) GP LLP
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Grants received
5 grants · £2,372,782 total360Giving data, published by funders. Coverage only includes funders who publish their grants to 360Giving, so these figures are a floor, not a complete picture.
Top funders
- Department for Business, Energy and Industrial Strategy · £1,398,021 (3 grants)
- Department for Science, Innovation and Technology · £974,761 (2 grants)
Most recent
- Department for Science, Innovation and Technology
- Department for Science, Innovation and Technology
- Department for Business, Energy and Industrial Strategy
- Department for Business, Energy and Industrial Strategy
- Department for Business, Energy and Industrial Strategy
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
6 directors on the board
- Kevin Lee Director · appointed 2021
- Dr Carmine Daniel Circelli Director · appointed 2026
- Dame Catherine Elizabeth Bingham Director · appointed 2023
- Dr Andrew Paul May Director · appointed 2026
- Jane Katharine Osbourn Director · appointed 2024
- Jenna Hebert Director · appointed 2026
First-time vs portfolio directors
First-time (3)
- Dr Andrew Paul May Director · appointed 2026
- Jane Katharine Osbourn Director · appointed 2024
- Jenna Hebert Director · appointed 2026
Portfolio (3)
- Kevin Lee Director · appointed 2021
- Dr Carmine Daniel Circelli Director · appointed 2026
- Dame Catherine Elizabeth Bingham Director · appointed 2023
Left in the last 12 months
- John Hamer Director · appointed 2021 · resigned 2026
- Andrew David Levin Director · appointed 2021 · resigned 2026
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 12156844
- Status
- Active
- Type
- Private Limited Company
- Accounts next due
- 30/09/2027
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data